Infant Bacterial Therapeutics AB
IBT-B.ST
#9237
Rank
A$0.11 B
Marketcap
$8.60
Share price
-0.56%
Change (1 day)
-30.39%
Change (1 year)

Infant Bacterial Therapeutics AB (IBT-B.ST) - Cash on Hand

Cash on Hand as of December 2024 : A$31.67 Million

According to Infant Bacterial Therapeutics AB's latest financial reports the company has A$31.67 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Infant Bacterial Therapeutics AB - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$32.57 M-32.07%
2023-12-31A$47.96 M1.05%
2022-12-31A$47.46 M-19.51%
2021-12-31A$58.96 M-12.31%
2020-12-31A$67.24 M-11.15%
2019-12-31A$75.68 M-11.69%
2018-12-31A$85.7 M245.79%
2017-12-31A$24.78 M73%
2016-12-31A$14.32 M97.62%
2015-12-31A$7.24 M4263.75%
2014-12-31A$0.16 M